Ypsomed Holding AG

SIX:YPSN.SW

427.5 (CHF) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 548.457497.46464.841403.656394.264453.765466.119389.555336.922306.632276.257244.565248.593242.461254.014272.58287.468277.45310.588241.823185.365137.187100.613
Cost of Revenue 359.403356.869351.024308.828303.29297.351326.293264.076233.735220.782205.731187.49192.221175.737187.568188.579197.271213.211191.375144.936113.6494.91774.954
Gross Profit 189.054140.591113.81794.82890.974156.414139.826125.479103.18785.8570.52657.07556.37266.72466.44684.00190.19764.239119.21396.88771.72542.2725.659
Gross Profit Ratio 0.3450.2830.2450.2350.2310.3450.30.3220.3060.280.2550.2330.2270.2750.2620.3080.3140.2320.3840.4010.3870.3080.255
Reseach & Development Expenses 23.27828.95321.95416.7884256.83840.55138.66432.25733.4627.71226.97909.2477.32410.46343.23521.90917.20640.581-6.397-4.559-0.795
General & Administrative Expenses 29.11426.21923.02921.09521.98124.0720.7218.15415.78215.5313.88412.75212.75450.36749.9144.24446.275-2.830.88735.04533.40723.50718.175
Selling & Marketing Expenses 78.87777.07466.39172.96467.17566.01661.38154.72146.41844.67941.52941.36840.58000021.41119.3890000
SG&A 107.991103.29389.4294.05989.15690.08682.10172.87562.260.20955.41354.1253.33450.36749.9144.24446.27518.58120.27635.04533.40723.50718.175
Other Expenses 000042001.7761.71900-1.892-2.102-1.5-4.2360.309-30.289-0.148-0.066027.4859.1181.59
Operating Expenses 107.991103.29389.4294.05989.15686.66278.29469.75259.50661.28654.2752.22851.23258.11452.99853.57559.22161.90156.87175.62654.49528.06618.97
Operating Income 81.06337.29824.3970.7691.81873.16460.86855.28344.25426.94515.5444.8465.148.6113.44930.42630.9762.33862.34221.26117.2314.2046.689
Operating Income Ratio 0.1480.0750.0520.0020.0050.1610.1310.1420.1310.0880.0560.020.0210.0360.0530.1120.1080.0080.2010.0880.0930.1040.066
Total Other Income Expenses Net 0.80919.3391.1435.3446.036-3.2841.0830.108-1.057-3.211-0.301-1.7644.597-0.935-1.651-4.245-1.2910.8442.0924.404-2.778-0.0140.106
Income Before Tax 81.87256.63725.546.1137.85469.8861.95155.39143.19723.73415.2433.0829.7387.67511.79726.18129.6853.18264.43245.66514.45214.196.795
Income Before Tax Ratio 0.1490.1140.0550.0150.020.1540.1330.1420.1280.0770.0550.0130.0390.0320.0460.0960.1030.0110.2070.1890.0780.1030.068
Income Tax Expense 3.5065.3622.4350.302-3.889.7449.8919.1447.3854.3391.6351.4351.2382.4692.3720.015-3.1030.448.784-6.472.8622.1291.019
Net Income 78.36651.27523.1055.81111.73460.13652.0646.24735.81219.39513.6081.6468.55.2069.42526.16626.5832.74255.64839.19511.5912.0615.776
Net Income Ratio 0.1430.1030.050.0140.030.1330.1120.1190.1060.0630.0490.0070.0340.0210.0370.0960.0920.010.1790.1620.0630.0880.057
EPS 5.743.821.820.460.934.774.143.672.841.541.080.130.670.430.792.322.360.244.933.481.254,810.930.51
EPS Diluted 5.743.821.820.460.934.774.143.672.841.541.080.130.670.430.792.322.360.244.933.481.254,810.930.51
EBITDA 155.929115.85892.47856.79454.61798.99580.67275.19364.64447.41335.32230.46131.90435.35741.93759.56955.59728.5889.87943.07247.31427.64818.662
EBITDA Ratio 0.2840.2330.1990.1410.1390.2180.1730.1930.1920.1550.1280.1250.1280.1460.1650.2190.1930.1030.2890.1780.2550.2020.185